Litigation

Recent Posts

And The Beat Goes On. . . Medicaid Fraud Suits Continue Churning and Returning Taxpayer Money Paid To Medical Providers
Posted on 11 Sep 2012 by LexisNexis Litigation Resource Community Staff

In anticipation of the upcoming U.S. presidential election, the news cycle is heating up with discussions about federal and state budget deficits and funding for Medicare/Medicaid programs. Both the Republican and Democratic Parties are lining up and... Read More

Tags: LexisNexis Jury Verdicts and Settlements Team , False Claims Act , Medicare , Insurance Fraud , Abbott Laboratories , verdicts and settlements , United States , Fraud , Medicaid , SCAN Health Plan , NextCare , LexisNexis , Litigation , GlaxoSmithKline , qui tam , ex rel. Greg Thorpe v. GlaxoSmithKline , DaVita Inc. , medical providers , express scripts

Abbott Withdraws Diet Pill Meridia In United States, Canada
Posted on 8 Oct 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. — (AP) Abbott Laboratories said Friday it will withdraw its diet pill Meridia in the U.S. and Canada, after coming under pressure from health regulators who say the drug increases the risk of heart attack and stroke in patients... Read More

Tags: weight loss , Wyeth , Vivus Inc. , Dr. John Jenkins , Food and Drug Administration , Abbott Laboratories , diet drugs , diet pill , Meridia , FDA , fen-phen , Arena Pharmaceuticals , Litigation , lawsuit , Roche , Health Canada , Xenical , Qnexa

7th Circuit Says Motion To Consolidate Depakote Suits Triggers CAFA Jurisdiction
Posted on 17 Oct 2012 by Tom Moylan

CHICAGO - Resolving a split between two district courts, the Seventh Circuit U.S. Court of Appeals on Oct. 16 ruled that plaintiffs' motions to consolidate 10 Illinois state court cases involving Abbott Laboratories' anti-seizure drug Depakote... Read More

Tags: Illinois , CAFA , Depakote , In Re: Abbott Laboratories Inc. , Seventh Circuit , birth defects , Abbott Laboratories , anti-seizure drug , St. Clair County Circuit Court , Litigation , Illinois Supreme Court , Class Action Fairness Act , Cook County Circuit Court

Abbott Withdraws Diet Drug Meridia From U.S. Market
Posted on 8 Oct 2010 by Tom Moylan

ABBOTT PARK, Ill. - (Mealey's) After an unfavorable assessment by a Food and Drug Administration expert committee regarding cardiovascular risk, Abbott Laboratories on Oct. 8 agreed with an FDA request to withdraw the weight-loss drug Meridia (sibutramine... Read More

Tags: sibutramine , weight loss , Sibutramine Cardiovascular Outcomes Trial , Steering Committee v. Abbott Laboratories , Center for Drug Evaluation and Research , Food and Drug Administration , Abbott Laboratories , diet drugs , SCOUT , Meridia , FDA , Office of New Drugs , Litigation , multidistrict litigation , Endocrinologic and Metabolic Drugs Committee , Meridia Products Liability Litigation , MDL , John Jenkins , black-box warning

Abbott To Pay $1.5 Billion In Civil, Criminal Penalties For Depakote Off-Label Promotion
Posted on 8 May 2012 by Tom Moylan

ABINGDON, Va. - Abbott Laboratories Inc. on May 7 pleaded guilty to one misdemeanor criminal charge and agreed to pay $1.5 billion in criminal fines, civil penalties and forfeiture for off-label marketing its anti-epilepsy drug Depakote despite knowing... Read More

Tags: drugs , Depakote , off-label marketing , Abbott Laboratories , epilepsy , Virginia Medicaid Fraud Control Unit , Food Drug and Cosmetic Act , FDCA , Litigation

Williams Mullen: Corporate Spin-Off, New Retirement Plan Did Not Violate Employees’ Rights Under ERISA
Posted on 16 Feb 2012 by Williams Mullen

Nauman v. Abbott Laboratories , No. 10-2272 (7th Cir. February 3, 2012) B y Mark S. Thomas and Robert W. Shaw The U. S. Court of Appeals for the Seventh Circuit has affirmed a trial judgment against a class of former employees of Abbott Laboratories... Read More

Tags: ERISA , Seventh Circuit , Mark S. Thomas , Abbott Laboratories , HPD , Employee Retirement Income Security Act , pension benefits , Williams Mullen , Hospira , Litigation , Nauman v. Abbott Laboratories , Robert W. Shaw , Hospital Products Division

Illinois Jury Awards $2.2Million To Widower In 1st Humira Infection Case To Go To Trial
Posted on 10 May 2013 by Tom Moylan

CHICAGO - (Mealey's) An Illinois state court jury on May 9 found Abbott Laboratories negligent and ordered it to pay a plaintiff $2,244,063 for a near-fatal infection his late wife suffered while taking the rheumatoid arthritis drug Humira, according... Read More

Tags: Illinois , drugs , Humira , histoplasmosis , Abbott Laboratories , arthritis drug , et al. v. Abbott Laboratories , Kidd & Vickery , Milton Tietz , Litigation , mmunosuppressant , Perdue , verdict , Delores Tietz , Cook County Circuit Court

California High Court: Pharmacies That 'Passed On' Higher Costs Have UCL Injury
Posted on 12 Jul 2010 by Bryan Redding

SAN FRANCISCO - (Mealey's) Pharmacies have standing to pursue unfair competition law (UCL) claims alleging that they paid higher prices because of price fixing by pharmaceutical companies, even though they passed the higher prices on to consumers... Read More

Tags: pharmacies , Eli Lilly & Co. , Hanover Shoe v. United Shoe Mach , Johnson & Johnson Health Care Systems Inc. , Boehringer Ingelheim Pharmaceuticals , pharmaceutical companies , Pharmaceutical Research and Manufacturers of America , James Clayworth , Abbott Laboratories , Pfizer Inc. , Wyeth Pharmaceuticals , California , UCL , Amgen Inc. , Allergan Inc. , Illinois Brick Co. v. Illinois , Business and Professions Code , price fixing , Cartwright Act , unfair competition law , AstraZeneca International , California Supreme Court , Novartis Pharmaceuticals Corp. , Hoffman-LaRoche Inc. , Litigation , lawsuit , Merck & Co. , Bristol-Myers Squibb Co.

Boehringer Ingelheim Pays $95 Million To Settle Off-Label, Kickback Claims In Civil Suit
Posted on 27 Oct 2012 by Tom Moylan

BALTIMORE — Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to the federal government to resolve civil allegations that it marketed three drugs for off-label uses, promoted high doses of two drugs and paid kickbacks to health care... Read More

Tags: off-label uses , False Claims Act , Boehringer Ingelheim Pharmaceuticals , Abbott Laboratories , chronic obstructive pulmonary disease , Micardis , COPD , Atrovent , Robert Heiden , hypertension , Aggrenox , bronchospasm , Medicaid , Litigation , lawsuit , Settlement , United States of American v. Boehringer Ingelheim , Combivent , kickbacks

Kos Pharmaceuticals Pays $41M For Kickbacks, Off-Label Promotion Of Cholesterol Drugs
Posted on 9 Dec 2010 by Tom Moylan

BATON ROUGE, La. - (Mealey's) The Kos Pharmaceuticals subsidiary of Abbott Laboratories Inc. on Dec. 7 entered into a deferred prosecution agreement and agreed to pay a total of $41 million in criminal penalties and False Claims Act settlement for... Read More

Tags: False Claims Act , Medicare , Nanci Johnson , Abbott Laboratories , Ruth Westover , cholesterol drugs , Litigation , lawsuit , Advicor , Kos Pharmaceuticals , Theresa Lakebrink , Niaspan , kickbacks